Type
- ARTG (106)
- Cancellation by sponsor (27)
- Prescription medicine registration (19)
- Australian Public Assessment Report (AusPAR) (13)
- Section 14, TGO91 consent (3)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Prescription medicine evaluation (2)
- Cancellation or suspension (1)
Sponsor content
175 result(s) found, displaying 31 to 40
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Sep-2025Prescription medicine evaluationActive ingredient: Bempedoic acid, ezetimibe.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial.
-
Australian Public Assessment Report (AusPAR)Onakta (tirbanibulin) was approved for the topical field treatment of actinic keratosis of the face or scalp in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUAD QUAD prefilled syringe(Influenza Surface Antigen,MF59C.1 adjuvanted vaccine).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TAVNEOS avacopan 10 mg hard capsule bottle.